With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading ...

Supporters say they won't stop campaigning to award Paddy Mayne a Victoria Cross, describing the SAS legend as a "hero who ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement ...

The week has ended with a flurry of M&A in the drug industry, with Cosette Pharmaceuticals agreeing to buy Australia's Mayne ...

US pharma giant Cosette has offered $7.40 a share for Mayne Pharmaceuticals, a premium to recent trading but a fraction of ...

Little Elm junior Aidan Mayne is just in his second year of wrestling in the state's largest classification, but it hasn't ...

Mayne Pharma’s largest individual shareholder, billionaire pub baron Bruce Mathieson, has backed US giant Cosette’s $672m ...

US drugmaker Cosette Pharmaceuticals has entered into a definitive agreement to acquire all the outstanding shares of ...

These shares are ending the week with a bang. Here's why they are jumping. The post Why Domain, Mayne Pharma, QBE, and Telix ...

This share is rocketing on Friday after accepting a takeover offer. The post Can you guess which ASX 300 healthcare stock is ...

周一，Canaccord Genuity将Mayne Pharma Group Ltd. (MYX:AU) (OTC: MAYNF)的评级从买入下调至持有，并将目标价从此前的6.25澳元上调至7.40澳元。此次调整是在Mayne Pharma宣布将被Cosette Pharma以每股7.40澳元收购后做出的，该交易总价值为6.72亿澳元。